NASDAQ:URGN | Key Financial Ratios | UroGen Pharma Ltd.

Complete source-backed ratio history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-303.8-38.65%73.75%
2026-03-314.69-52.51%107.22%
2025-12-314.01-76.57%145.53%
2025-09-303.99-88.97%142.66%
2025-06-304.14-74.25%165.96%
2025-03-315.65-55.91%297.97%
2024-12-316.01-44.41%1441.26%
2024-09-309-38.21%-452.20%
2024-06-308.15-40.30%-374.69%
2024-03-317.47-52.01%259.92%
2023-12-315.42-57.34%156.79%
2023-09-307.06-54.28%250.27%
2023-06-303.04-114.35%78.77%
2023-03-313.8-98.80%95.75%
2022-12-315.39-80.95%122.85%
2022-09-306.4-85.13%172.81%
2022-06-307.74-77.83%278.02%
2022-03-318.41-68.36%663.45%
2021-12-315.11-92.55%-1317.25%
2021-09-306.32-83.87%-357.97%
2021-06-307.37-72.51%-198.15%
2021-03-315.47-119.72%-152.47%
2020-12-315.39-105.31%-133.34%
2020-09-307.34-97.88%-113.61%
2020-06-307.91-80.93%-91.38%
2020-03-318.58-72.78%-80.75%
2019-12-317.63-51.95%-58.32%
2019-09-3011.35-39.64%-42.62%
2019-06-3016.14-36.96%-39.23%
2019-03-3124.16-33.22%-34.94%
2018-12-317.59-73.06%-83.98%
2018-09-3012.42-55.11%-59.88%
2018-06-3015.18-34.40%-36.80%
2018-03-3123.26-23.16%-24.19%
2017-12-3110.59-26.47%-29.19%
2016-12-317.03

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-314.01-76.57%145.53%
2024-12-316.01-44.41%1441.26%
2023-12-315.42-57.34%156.79%
2022-12-315.39-80.95%122.85%
2021-12-315.11-92.55%-1317.25%
2020-12-315.39-105.31%-133.34%
2019-12-317.63-51.95%-58.32%
2018-12-317.59-73.06%-83.98%
2017-12-3110.59-26.47%-29.19%
2016-12-317.03-8.42%-11.90%
2015-12-31-77.94%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.